Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer

Clinical trial NCT00031278 · COMPLETED

Trial details

NCT number: NCT00031278
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Metastatic Breast

Start date: 2001-10-01
Primary completion: 2003-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.